Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.43 |
| ▸ | CCR2 | P41597 | 15/20 | 0.42 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.41 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24718273 | 0.91 | TP53 (0.47) | TP53RIPK1SIRT2SIRT1P2RX7 | |
| SCHEMBL24719125 | 0.90 | TP53 (0.51) | TP53RIPK1CCR2SIRT2SIRT1 | |
| SCHEMBL24718304 | 0.90 | TP53 (0.47) | TP53RIPK1CCR2SIRT2SIRT1 | |
| SCHEMBL24718382 | 0.90 | TP53 (0.46) | TP53RIPK1SIRT2SIRT1P2RX7 | |
| SCHEMBL24718241 | 0.90 | TP53 (0.46) | TP53RIPK1SIRT2SIRT1P2RX7 | |
| SCHEMBL24718416 | 0.90 | TP53 (0.46) | TP53RIPK1SIRT2SIRT1P2RX7 | |
| SCHEMBL24718281 | 0.84 | TP53 (0.46) | TP53RIPK1SIRT2SIRT1P2RX7 | |
| SCHEMBL24718827 | 0.82 | TP53 (0.49) | TP53RIPK1SIRT2SIRT1P2RX7 | |
| SCHEMBL24718839 | 0.82 | TP53 (0.49) | TP53RIPK1SIRT2SIRT1P2RX7 | |
| SCHEMBL24718637 | 0.82 | TP53 (0.49) | TP53RIPK1SIRT2SIRT1P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220363633-A1 | SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING | UNITED STATES GOVERNMENT | 2022-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220363633-A1 | SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING | EED, EZH2, ELP1 | TP53 284/4885RIPK1 1371/4885CCR2 3257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.